section 241 of this titleIn carrying out , the Secretary may make grants to public and nonprofit private entities, and may enter into contracts with public and private entities and individuals, for projects for (1) basic or applied research leading to the understanding, diagnosis, treatment, and control of genetic diseases, (2) planning, establishing, demonstrating, and developing special programs for the training of genetic counselors, social and behavioral scientists, and other health professionals, (3) the development of programs to educate practicing physicians, other health professionals, and the public regarding the nature of genetic processes, the inheritance patterns of genetic diseases, and the means, methods, and facilities available to diagnose, control, counsel, and treat genetic diseases, and (4) the development of counseling and testing programs and other programs for the diagnosis, control, and treatment of genetic diseases. In making grants and entering into contracts for projects described in clause (1) of the preceding sentence, the Secretary shall give priority to applications for such grants or contracts which are submitted for research on sickle cell anemia and for research on Cooley’s anemia.
July 1, 1944, ch. 373Pub. L. 94–278, title IV, § 403(a)90 Stat. 408(, title XI, § 1102, as added , , .)
Editorial Notes
Prior Provisions
act July 1, 1944, ch. 373, title XI, § 1102Pub. L. 92–294, § 3(c)86 Stat. 138Pub. L. 94–278, title IV, § 403(a)90 Stat. 407A prior section 300b–1, , as added , , , authorized Secretary to make grants and enter contracts with public and private entities and individuals for projects concerned with research, research training in diagnosis, treatment and control of sickle cell anemia, informational and educational programs with respect to sickle cell anemia and development of counseling and testing programs, prior to repeal by , , .
Statutory Notes and Related Subsidiaries
Effective Date
Pub. L. 94–278, title IV, § 403(c)90 Stat. 410
Short Title of 1976 Amendment
Pub. L. 94–278section 401 of Pub. L. 94–278section 201 of this titleFor short title of title IV of , which enacted this part, omitted former part B of this subchapter, redesignated former parts C and D of this subchapter as parts B and C of this subchapter, respectively, as the “National Sickle Cell Anemia, Cooley’s Anemia, Tay-Sachs, and Genetic Diseases Act”, see , set out as a note under .
Demonstration Program for the Development and Establishment of Systemic Mechanisms for the Prevention and Treatment of Sickle Cell Disease
Pub. L. 108–357, title VII, § 712(c)118 Stat. 1559Pub. L. 115–327, § 3(a)132 Stat. 4469section 300b–5(b) of this titlePub. L. 115–327, § 3(b)132 Stat. 4470, , , as amended by , , , which was formerly set out as a note under this section, was transferred to by , , .
Congressional Declaration of Purpose
Pub. L. 94–278, title IV, § 40290 Stat. 407Pub. L. 95–626, title II, § 205(a)92 Stat. 3583Pub. L. 111–256, § 2(i)124 Stat. 2644
section 2 of Pub. L. 111–256section 2(k) of Pub. L. 111–256section 1400 of Title 20[For meaning of references to an intellectual disability and to individuals with intellectual disabilities in provisions amended by , see , set out as a note under , Education.]